CAJ | 학술논문

目的观察培美曲塞二钠联合顺铂治疗晚期非鳞非小细胞肺癌患者的近期临床疗效和毒性反应.方法 20例Ⅲb～Ⅳ期非鳞非小细胞肺癌患者均经病理组织学和(或)细胞学检查确诊.培美曲塞二钠联合顺铂治疗2个周期后评价疗效.结果 20例患者均可评价,获得完全缓解(CR)0例,部分缓解(PR)9例,有效率为45.0%(9/20).最主要的不良反应为骨髓抑制,但均可耐受.结论培美曲塞二钠联合顺铂治疗晚期非鳞非小细胞肺癌有较好疗效,不良反应轻,易于耐受.
목적 관찰배미곡새이납연합순박치료만기비린비소세포폐암환자적근기림상료효화독성반응.방법 20례Ⅲb～Ⅳ기비린비소세포폐암환자균경병리조직학화(혹)세포학검사학진.배미곡새이납연합순박치료2개주기후평개료효.결과 20례환자균가평개,획득완전완해(CR)0례,부분완해(PR)9례,유효솔위45.0%(9/20).최주요적불량반응위골수억제,단균가내수.결론 배미곡새이납연합순박치료만기비린비소세포폐암유교호료효,불량반응경,역우내수.
Objective To observe the clinical efficacy and adverse effect of pemetrexed disodium combined with cisplatin in treating advanced non-small cell lung cancer of nonsquamous cell histology. Methods A total of 20 patients with advanced non-small cell lung cancer of nonsquamous cell histology diagnosed by pathology or cytology were enrolled into the study.The patients were treated with pemetrexed disodium and cisplatin. Each patient was received 2 cycles chemotherapy at least. The short-term effect,side effects were evaluated after chemotherapy. Results Complete remission (CR)was observed in 0 case and PR in 9 cases.The response rate(RR) was 45.5% (9/20).The main side effects were bone marrow suppression,but that was tolerable. Conclusions The regimen of pemetrexed disodium combined with cisplatin is effective,safe and well tolerable in the treatment of non-small cell lung cancer of nonsquamous cell histology.